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Abstract
Cyclin-dependent kinases (CDKs) are a family of serine/threonine kinases essential for cell cycle progression. Herein, we
describe the participation of CDKs in the physiology of Rhipicephalus microplus, the southern cattle tick and an important
disease vector. Firstly, amino acid sequences homologous with CDKs of other organisms were identified from a R. microplus
transcriptome database in silico. The analysis of the deduced amino acid sequences of CDK1 and CDK10 from R. microplus
showed that both have caspase-3/7 cleavage motifs despite their differences in motif position and length of encoded
proteins. CDK1 has two motifs (DKRGD and SAKDA) located opposite to the ATP binding site while CDK10 has only one
motif (SLLDN) for caspase 3–7 near the ATP binding site. Roscovitine (Rosco), a purine derivative that inhibits CDK/cyclin
complexes by binding to the catalytic domain of the CDK molecule at the ATP binding site, which prevents the transfer of
ATP’s cphosphoryl group to the substrate. To determine the effect of Rosco on tick CDKs, BME26 cells derived from R.
microplus embryo cells were utilized in vitro inhibition assays. Cell viability decreased in the Rosco-treated groups after
24 hours of incubation in a concentration-dependent manner and this was observed up to 48 hours following incubation.
To our knowledge, this is the first report on characterization of a cell cycle protein in arachnids, and the sensitivity of BME26
tick cell line to Rosco treatment suggests that CDKs are potential targets for novel drug design to control tick infestation.
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Introduction
Protein phosphorylation is a major mechanism for controlling
protein activity. This leads to increased or decreased enzymatic
activity or when the phosphorylation target is a transcription
factor, it results in enhanced or decreased expression of the target
genes. When the phosphorylation target is a regulatory protein the
phosphorylation may turn on/off a metabolic pathway. The
regulatory function of protein kinases has been known for several
decades but the extent of this control mechanism has only been
recognized fully in the recent past [1] and is now known that 5%
of the proteins in any genome are eventually phosphorylated [2].
There are two major groups of protein kinases: one comprising
proteins that catalyze the insertion of a phosphate group in the
alcoholic hydroxyl present on the side chain of serine and
threonine of the target proteins (Ser/Thr protein kinases), and
another that catalyzes the insertion of a phosphate group in the
phenolic hydroxyl present in the side chain of tyrosine. Some
protein kinases use ATP as phosphate group donors and others use
GTP or some other high-energy phosphate compounds as a
phosphate source. Because of their role in signal transduction, this
group of proteins has been targeted for drug design aiming to
control several pathologic states, such as cancer and inflammatory
diseases [3,4].
Some proteins, like hemoglobin, have a half-life of several
months [5]. However, others, including some proteins that control
cell cycle division have a half-life of 3 minutes and an imperfection
in cell cycle control may result in the development of cancer.
Throughout the cell cycle there are checkpoints to ensure that
every step of cell division is completed correctly and that the
daughter cells are identical to the mother cells. A specific group of
enzymes of the family called ‘‘protein-kinases activated cyclically’’
play a central role in cell cycle control. The protein family
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responsible for activation or deactivation of those protein-kinases is
known as cyclins since their concentration varies sharply during
the cell cycle, with degradation occurring after the checkpoint
under their control [6]. Protein kinases, which act exclusively in
the presence of cyclins, are called cyclin-dependent kinases (CDKs)
[7]. CDKs are the catalytic subunits of heterodimeric complexes
briefly activated at specific stages of the cell cycle, and their
regulation triggers the next cell cycle events [8].
Negative controllers of cell cycle act by inactivating the
functions of positive controllers leading to the cell cycle arrest
and apoptosis (programmed cell death) [9]. These are described as
intrinsic and extrinsic negative controllers (inhibitors). The
intrinsic inhibitors of CDKs are cell proteins that block the
activity of CDK-cyclin complexes [10] and extrinsic CDK
inhibitors are chemicals that inhibit the function of CDKs.
One of the extrinsic CDK inhibitors most often studied in
cancer treatment is roscovitine (Rosco), a purine derivative that
inhibits CDK1/cyclin B, CDK2/cyclin A or E, CDK5/p25,
CDK7/cyclin H, and CDK9/cyclin T in vitro kinase assays. Rosco
inhibits CDKs by binding to the catalytic domain of the CDK
molecule in place of ATP, which prevents the transfer of the
phosphate group to the substrate. It is commonly used as a potent
antitumor drug, having high specificity to CDK, and being applied
not only as a chemotherapeutic agent, but has also been described
as an inhibitor of the cell cycle, when present in low concentrations
[11,12]. Ticks are the major ectoparasites of livestock and cause
vast economical losses worldwide [13] by transmitting numerous
pathogens to humans and animals [14]. Many tick species
however have shown resistance against existing pesticides neces-
sitating the search for more potent acaracides [15]. To our
knowledge, there are no studies addressing the role of cell cycle
controllers and involvement in the embryonic development in
arthropod disease vectors such as the tick Rhipicephalus microplus.
Here we present a study of the effects of roscovitine, a CDK
inhibitor, on the growth and survival in vitro of an embryonic tick
cell line (BME26), isolated from R. microplus embryos [16]. The
focus on the CDKs from R. microplus is in the context of identifying
suitable drug targets to control this ectoparasite at different stages
of its development.
Materials and Methods
Identification of CDK homologs from R. microplus
HomoloGene (http://www.ncbi.nlm.nih.gov/homologene) is a
system for automated detection of homologs among the annotated
genes of several completely sequenced eukaryotic genomes.
HomoloGene (release 67) was used to selectively download protein
sequences of the twenty variants of CDK.
Protein sequences representatives of CDKs from Homo sapiens,
Bos taurus, Mus musculus, Gallus gallus, Danio rerio, Drosophila
melanogaster, Anopheles gambiae and Caenorhabditis elegans,
when available, were downloaded from this database. These
proteins were further used as queries to conduct BLAST searches
[17] in a protein database of R. microplus (unpublished data)
assembled from annotation of comprehensive R. microplus
transcriptome (seven organs/tissues of R. microplus, obtained at
various stages of development). The cDNA produced was
sequenced by Illumina technology following the database assembly
(unpublished data). In addition, the sequences obtained of R.
microplus proteins were used to search for the corresponding
CDK protein homologs in Ixodes scapularis, the only tick species
whose genome has been sequenced [18]. A FASTA-formatted file
comprising of all of the downloaded sequences, their Gene Index
and accession numbers is provided (Figure S1). The sequences of
R. microplus and the deduced proteins of I. scapularis are also
included in this file. In some cases the sequences obtained from the
transcriptome were not complete but the presence of a protein
kinase domain (pfam00069) was confirmed in all cases. Eukaryotic
Linear Motif Resource (http://elm.eu.org/) was used to determine
the presence of the specific motifs.
Alignment and Phylogenetic analyses
Classification of R. microplus CDKs by similarity to a
restricted group of model proteins. As a first approach to
confirm the classification of the nine putative CDK proteins
obtained solely by blast homology with CDKs of model organisms,
a phylogenetic tree was built using only CDKs found in R.
microplus, and their best matches from H. sapiens, the best studied
model, B. taurus, R. microplus host, and Aedes aegypti, an important
model for vector-borne diseases. This tree was constructed by the
neighbor-joining method using 5.1 MEGA software [19] and with
500 simulations to calculate bootstrap values.
Phylogenetic analysis of the R. microplus CDKs among
the complete set of the 20 known CDK isoforms. A more
extensive phylogenetic tree was build using Mega 5.1 software with
representatives of the 20 types of CDKs from H. sapiens, B. taurus,
M. musculus, G. gallus, D. rerio, D. melanogaster, A. gambie and C. elegans
found in HomoloGene, together with the nine proteins deduced
from transcriptome of R. microplus (Gene bank accession number
KC968965 to KC968973) that bear sequence similarities with
model CDKs. Two other proteins found during the transcriptome
analysis that are important players in cell cycle progression – Nima
(Never in mitosis) (KC968974) and Aurora kinase (KC968975) –
were included in this analysis both to demonstrate that they are
not CDKs and also to have an external group. The eight CDKs-
like sequences retrieved from I. scapularis gene database were also
included in this analysis. This phylogenetic tree was constructed as
before (Figure S2).
Molecular modeling
Construction of three dimensional models of CDKs from
R. microplus by comparative modeling. Three-dimensional
models of CDKs from R. microplus were constructed by compar-
ative modeling using the CPH models 3.2 server (http://www.cbs.
dtu.dk/services/CPHmodels/) [20], which combines sequence,
structural and functional information. The template recognition is
based on profile-profile alignment guided by secondary structure
and exposure predictions. The accurate template determination
and sequence alignment algorithm enhances the reliability of the
3D structure.
Models’ validation. The quality of comparative models can
be assessed on the basis of both geometric and energetic aspects. In
this study, structural analysis (validation phase) of the CDK models
from R. microplus was performed using the protein analysis tools
available on the Structural Analysis and Verification Server
(http://nihserv-110er.mbi.ucla.edu/SAVES/). Visual inspections
of the three-dimensional models were made in the program
PyMOL version 0.99 for Windows [21], available for download at
http://www.pymol.org/.
Docking simulations. The structure of roscovitine was built
in the software Spartan’ 08 for Windows (Wavefunction, Inc.).
Conformational analysis, geometry optimization and charge
assignment were carried out with the semi-empirical method
AM1 [22]. The CHEMSCORE_KINASE fitness function in
GOLD docking software version 4.1.2 [23] was used to score the
docked compounds. The active site was defined as all atoms within
10 Å from O768 from Val140, in CDK1 and O810 from Cys147
in CDK10 models, respectively, which have been used as
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reference residues for binding site definition in GOLD software.
The protein-ligand complexes with the most favorable Fitness
score values among the top scored complexes were used for further
visual inspection, which has been done with Pymol v. 0.99 [21].
Cloning of CDK1 and CDK10 from R. microplus ovary
RNA was isolated from ovaries of fully engorged female R.
microplus (Porto Alegre isolate) ticks using TRIZOL reagent
according to the manufacturers’ instructions. Complementary
DNA (cDNA) was subsequently synthesized from total RNA by
using SuperscriptH III reverse transcriptase and oligo (dT) 12–18
primer. PCR were performed using specific primers designed from
R. microplus CDK sequences retrieved from the transcriptome
database.
The primers used were FOR-1 (59- GGGGGCAGTC-
GAAGCGG -39) which corresponds to the 59 end, and REV-1
(59- AAATACTGATGTTTGAGG -39), which corresponds to the
39 end of Rm-CDK1 and FOR-10 (59- ATGGAAGCCGGCA-
TAAATCAAC -39) which corresponds to the 59 end, and REV-10
(59- TCAGATGAAGTCTGCAGTCT -39), which corresponds to
Figure 1. Phylogenetic analysis of R. microplus, A. aegypti, B. taurus and H. sapiens CDK sequences constructed by the neighbor-
joining method using 5.1 MEGA software. Bootstrap values of 500 simulations are shown at the branches. Nine CDK isoforms found in R.
microplus and the homologous sequences from H. sapiens, B. taurus and A. aegypti fell within specific clades corresponding to the nine CDK isoforms
reported in other organisms.
doi:10.1371/journal.pone.0076128.g001
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the 39 end of Rm-CDK10. The amplicons were purified on
agarose gels and ligated into the pGEM-T vector (Promega), and
transformed into DH5a strain of Escherichia coli. The cloned insert
were sequenced on a P/ACETM MDQ-Beckman Coulter, Inc.
Automated sequencer.
BME26 cell line
Cells were maintained following a previously described protocol
[16]. Briefly, adherent cells from 25 cm2 confluent flasks were
suspended into a fresh complete medium using a 22-gauge needle
with a bent tip fitted to a plastic syringe. Cells were passaged every
3–4 weeks, and the medium replaced weekly. Culture density was
determined with a Neubauer hemocytometer and cell viability was
determined by the trypan blue exclusion (0.4%) method. Two
weeks prior to their use in assays, the synchronized cells were
prepared by seeding 16107 cells into 5 mL of fresh complete
medium (final volume), and growing them at 34uC to ensure
doubling (within 2 weeks), finally the medium was replaced weekly.
Viability assay
BME26 cell suspension was seeded into 24-well plates at a
density of 56105 cells/well, to a final volume of 500 mL of
complete medium and allowed to attach. After 24 h at 34uC,
roscovitine was added at the final concentrations indicated
(75 mM, 150 mM, 175 mM, 200 mM or 225 mM), and 0.1%
DMSO was used in negative control wells. After 24 or 48 h of
treatment, 50 mL of tetrazolium salt MTT prepared in serum-free
medium (5 mg/mL) was added to each well. After additional 2 h
incubation, the media was completely discarded and 1 mL of acid-
isopropyl alcohol (0.15% HCl in isopropyl alcohol) was added to
dissolve the formazan crystals. The mixture was transferred to
1.5 mL tubes, spun at 6,0006g for 15 min, and the clear
supernatant collected in new tubes for absorbance measurement
at 570 nm using quartz cuvettes in an UVmini-1240 UV-VIS
spectrophotometer (Shimadzu, Japan). Unless otherwise stated,
absorbance values of control treatment were used for normaliza-
tion (100% viability).
BME26 cell staining with hematoxylin-eosin staining (HE)
BME26 cells were plated (56105 cell/well) over glass coverslips
placed at the bottom of a 24-well plate to a final volume of 500 mL
of complete medium and allowed to attach. After 24 h at 34uC,
roscovitine was added at the final concentrations indicated
(75 mM; 150 mM; 175 mM; 200 mM; 225 mM), and 0.1% DMSO
was used in negative control wells. After 24 h of treatment, the
coverslips were removed from the plates and the staining was
performed [24]. Image J software was used to quantify the number
of cells per field in each treatment. Three independent experi-
ments for each treatment were performed in triplicates and every
replicate analyzed under 3 different fields with image J.
Transcription of Rm-CDK in BME26
The transcription of Rm-CDKs in BME26 cell was evaluated
by RT-PCR. Total RNA was extracted from cells using TRIzol
reagent (Invitrogen) following the manufacturer’s recommenda-
tions. One microgram of total RNA reverse-transcribed using the
Reverse Transcriptase M-MLV (Takara) and oligo(dT) primer.
Specific primers designed for gene amplifications are described in
Table S1. The reactions were performed according to the
following steps: 1 min at 94uC followed by 35 cycles of 1 min at
94uC, 30 s at 55uC, and 1 min at 72uC, with a final elongation at
72uC for 7 min. PCR products were electrophoresed on a 2%
agarose gel and visualized by staining with ethidium bromide. The
elongation factor 1a (ELF1A) gene primers were used as positive
control [25].
Results
Identification of putative R. microplus CDKs and selection
of Rm-CDK1 and Rm-CDK10 isoforms for further analyses
A local database with all protein sequences deduced from the
contigs assembled from RNA-Seq of R. microplus representative of
the tick transcriptome was constructed (unpublished data). Blast
searches for CDK-like proteins were performed in this database as
described in methods. At least 9 protein sequences similar to CDK
isoforms were found in R. microplus and tentatively named as Rm-
CDK1, Rm-CDK2, Rm-CDK5, Rm-CDK7, Rm-CDK8, Rm-
CDK9, Rm-CDK10, Rm-CDK11 and Rm-CDK14. Names were
based on the level of sequence similarity with homologs present in
HomoloGene. These CDK isoforms found in R. microplus and the
homologous sequences from H. sapiens, B. taurus and A. aegypti are
depicted in Figure 1. In all cases, the nine R. microplus derived
sequences fell within specific clades corresponding to the nine
CDK isoforms reported in other organisms. Most hematophagous
arthropods use the r-strategy for reproduction, characterized with
high fecundity. In the case of R. microplus, a single female can lay as
Table 1. CDK-gene read counts on RNA-Seq of R. microplus tissues.
CDK Ovary Embryo Synganglyon Salivary gland Fat body
Partially engorged
female Fully engorged female
CDK1 4503 320 158 409 523 543 101
CDK2 180 15 33 0 7 0 4
CDK5 3322 224 565 1093 567 822 127
CDK7 2379 92 852 222 603 372 494
CDK8 1272 133 532 155 184 118 125
CDK9 1130 40 69 58 58 56 18
CDK10 4844 381 605 946 1222 1176 224
CDK11 2759 373 492 873 430 758 218
CDK14 2159 47 47 202 154 157 63
CDKs orthologous proteins from R. microplus were identified in the available data obtained from a multi-tissue transcriptome. Messenger RNA was extracted from seven
tissues of female ticks harvested at several points of development and sequenced using Illumina technology.
doi:10.1371/journal.pone.0076128.t001
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many as 2,500 eggs. As a result, targeting the reproduction process
is an attractive point of intervention in controlling this ectopar-
asite. From the RNA-Seq output, the number of transcripts
corresponding to the R. microplus CDKs in various tick tissues were
computed (Table 1). Rm-CDK1 and Rm-CDK10 were found to
be expressed at the high levels in ovaries making them candidates
for subsequent investigation.
Cloning and sequence analyses of Rm-CDK 1 and Rm-
CDK 10 from the ovary of fully engorged tick females
An 870 bp cDNA product corresponding to Rm-CDK1 and
one measuring 1122 bp cDNA product corresponding to Rm-
CDK10 were amplified from the RNA of the ovary of fully
engorged tick females. The obtained sequences display high
similarity with CDKs of other organisms (figures 2 and 3). The
predicted mature protein for Rm-CDK1 contains 289 amino acids
(calculated Mw 33,456; isoelectric point 8.29) whereas Rm-
CDK10 contains 373 amino acids (calculated Mw 42,290;
Figure 2. Amino acid sequence alignment of CDK1s from R. microplus, A. aegypti, B. taurus, H. sapiens and I. scapularis. Sequences were
aligned using ClustalW. Conserved residues are black (100% conservation), dark grey (80% conservation), light grey (60% conservation) and no
shading denotes residues with ,60% conservation. Threonine residue in the activation loops is in red, protein kinases ATP-binding region signature
is in green and serine/threonine protein kinases active-site signature is in blue.
doi:10.1371/journal.pone.0076128.g002
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Figure 3. Amino acid sequence alignment of CDK10s from R. microplus, A. aegypti, B. taurus, H. sapiens and I. scapularis. Sequences were
aligned using ClustalW. Conserved residues are black (100% conservation), dark grey (80% conservation), light grey (60% conservation) and no
shading denotes residues with ,60% conservation. Threonine residue in the activation loops is in red, protein kinases ATP-binding region signature
is in green and serine/threonine protein kinases active-site signature is in blue.
doi:10.1371/journal.pone.0076128.g003
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isoelectric point 8.85). An alignment between CDK1 and CDK10
from R. microplus and those of other organisms show high residue
conservation that is characteristic of proteins with basic cellular
function. Specifically, CDK1 and CDK10 of R. microplus and B.
taurus (the host of tick) showed 80 and 76% predicted amino acid
similarities, respectively, (Figures 2 and 3).
Molecular modeling studies
Comparative Modeling of Rm-CDK1 and Rm-CDK10. R.
microplus CDK1 and CDK10 3D comparative models were
constructed based on the structures of human Cyclin Dependent
Kinase 2 (CDK2, PDB ID: 2v22; [26]) and the structure of human
Cyclin Dependent Kinase 9 (CDK9) (PDB ID: 3mi9; [27]) with
Figure 4. Structure of the comparative model of Rm-CDK1 showing the ATP binding Site (active site) (A) and detail of the activation
loop with the putative phosphorylating residue Thr164 (B).
doi:10.1371/journal.pone.0076128.g004
Figure 5. Structure of the comparative model of Rm-CDK10 showing the ATP binding Site (active site) (A) and detail of the
activation loop with the putative phosphorylating residue Thr223 (B).
doi:10.1371/journal.pone.0076128.g005
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40.51% and 63.67% of identity, respectively [28]. The 3D models
were subsequently validated for the geometric integrity. Rama-
chandran plots revealed that over 90% of the amino acid residues
are inside the allowed regions for both comparative models (Figures
S3 and S4).
Identification of functional motifs in CDK1 and CDK10
from R. microplus. The ATP binding pocket, the active sites
of Rm-CDK1 and Rm-CDK10 and the threonine residues in the
activation loops of CDK1 (Thr164) and CDK10 (Thr223) were
identified in a 3D model (Figures 4 and 5), supporting the presence
of a kinase motif for these proteins. Furthermore, the Caspase 3/7
recognition motif, with the consensus sequence and an aspartic
acid on the penultimate position that is essential for biological
function of the CDKs, was present in these sequences. In the
comparative 3D model of Rm-CDK1, two other motifs, opposite
to the ATP binding site were identified (Figure S5). The motif
DKRGD contains the amino acids Asp25, Lys26, Arg27, Asp28
and Gly29 in the N-terminus of the protein and the SAKDA
sequence, with the amino acid residues Ser280, Ala281, Lys282,
Asp283 and Ala284, in the C-terminus of the protein. In the
structure of Rm-CDK10, only a SLLDN motif for caspase 3–7
located near the ATP binding site was found, with the amino acid
residues Ser153, Leu154, Leu155, Asp156 and Asn157 (Figure
S6).
Simulations of roscovitine docking with Rm-CDK1 and
Rm-CDK10. Using the modeled 3D structures of Rm-CDKs1
and 10, a simulated docking of roscovitine on the two proteins
suggested a stable interaction (Figures 6 A–B for Rm-CDK1 and
Figures 7 A–B for Rm-CDK10). A putative interaction of
roscovitine in the ATP binding site was observed in both Rm-
CDKs. In both cases, the N-benzyl ring is oriented away from the
solvent accessible surface and onto the ATP binding pocket
(Figures 6B and 7B). In Rm-CDK1, one of the nitrogen atoms of
the purine ring of roscovitine hydrogen bonds to Tyr85 while the
nitrogen and the oxygen atoms of the hydroxyethylamino moiety
perform ion-dipole interactions with Asp89 and Lys92, respec-
tively (Figure 6A). Concerning Rm-CDK10, there are hydrogen
bonds involving the nitrogen atom of the purine ring and the
nitrogen and oxygen atoms on the hydroxyethylamino moiety of
roscovitine on one side, and the backbone oxygen of Cys147 and
Glu148 (Figure 7A). When this in silico analysis was compared with
experimental observations that show the binding of roscovitine to
human CDK2 (PDB ID: 2A4L; [29], for example, the putative
ATP binding sites of our 3D models adopt a more closed
conformation, and impairs the interaction with other proteins
(Figure S7). Furthermore, superimposition of Rm-CDKs1 and 10
models with the crystal structure of human CDK2 (Figure S8)
shows different binding modes, in which roscovitine performs
Figure 6. A, B: Top pose obtained by docking of roscovitine with Rm-CDK1 comparative model (yellow carbon atoms). Hydrogen
atoms have been omitted for a better view. Hydrogen bonds are depicted in blue dashed lines.
doi:10.1371/journal.pone.0076128.g006
Figure 7. A, B: Top pose obtained by docking of roscovitine with Rm-CDK10 comparative model (yellow carbon atoms). Hydrogen
atoms have been omitted for a better view. Hydrogen bonds are depicted in blue dashed lines.
doi:10.1371/journal.pone.0076128.g007
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more interactions than it is observed experimentally with human
CDK2 as stated previously. In the crystal structure, roscovitine
hydrogen bonds to a water molecule and to the oxygen atom of the
carbonyl group of Leu83 (Figure S7). Thus, despite amino acid
residue conservation in the ATP binding site, differences in Rm-
CDKs1 and 10 are enough to suggest different binding modes for
Roscovitine (Figures S8 and S9). However, it is not possible to rule
out the idea that conformational differences may have been
inherited by the templates used for modeling in the CPHModels
server. For instance, the careful analysis of the amino acid residues
surrounding Roscovitine binding site in human CDK2 shows, in
general, the same corresponding amino acid residues in the Rm-
CDK1 model. One noticeable difference is the inverted confor-
mation of the long side chain of Lys89 in human CDK2 vs. Lys92
in Rm-CDK1 (Figure S9), which is involved in an ion-dipole
interaction to Roscovitine in our Rm-CDK1 model and may have
oriented a different binding mode compared to human CDK2.
Another amino acid substitution worth mentioning is Phe82 in
CDK2, which has Tyr85 as the corresponding amino acid in Rm-
CDK1 model and is involved in hydrogen bonding with
Roscovitine in our model. Further differences have been observed
only in regions that are distant from the active site or the activation
loop (data not labeled). Nevertheless, when we compare amino
acid residues from Rm-CDK10 and human CDK2 (Figure S8),
the differences are not only conformational but also in the volume
and/or physicochemical characteristics of the amino acids in the
active site. For instance, Glu148, which is involved in a hydrogen
bond with Roscovitine in the Rm-CDK10 model has His84 as the
corresponding amino acid in human CDK2. Also, Cys147 in Rm-
CDK10 has been replaced by Leu83 in human CDK2 and, at the
surface of the active site, Arg269 in Rm-CDK10 has been replaced
by Asp206 in human CDK2, which provides a totally different
electrostatic environment to the active site. These data support the
fact that, overall, Rm-CDK10 is less conserved in the active site
than Rm-CDK1 when compared to human CDK2. Finally,
another point for discussion is the fact that water molecules have
not been modeled or included in the docking studies, though they
may have an important role in the binding affinity of Roscovitine.
3.4. Viability assay and inhibitory effect of roscovitine on
growth of BME26 Cells
BME26 cells were incubated with different concentrations of
roscovitine for 24 h or 48 h to assess the effect of the inhibitor on
the cells. Following 24 h incubation, the viability of the cells
decreased in a concentration-dependent manner. The cell number
was reduced to 80% (150 mm), 45% (175 mm), 30% (200 mm) and
26% (225 mm) relative to the control cells, which contained only
DMSO (Figure 8). The cytotoxic effect of roscovitine on BME26
cells was further pronounced after 48 h of incubation, with cell
viability dropping to 22% (75 mm), 9.6% (150 mm), 9% (175 mm),
7% (200 mm), and 4% (225 mm) relative to the control group
(Figure 8).
The susceptibility of embryonic tick cells to roscovitine was
further confirmed by hematoxylin and eosin (HE) staining that
assess the number of cells per field by marking the cell nucleus. As
evident from Figure 9, there was significant decline in the number
of cells per field following treatment with roscovitine concentra-
tions higher than 150 mM. Statistical significance of inhibitory
effect was analyzed with One-way analysis of variance—ANOVA.
Results are expressed, as mean 6S.D. p values #0.05 were
considered statistically significant.
Transcription of Rm-CDKs in BME26
RT-PCR analysis showed that Rm-CDK1, 2, 5, 7, 8, 10, 11 and
14 were transcribed in BME26 cells. Rm-CDK9 transcription was
not detectable in BME26 cells (Figure 10). In general, RT-PCR
results of BME26 cells are in agreement with the RNA-Seq
analysis of embryo (Table 1).
Discussion
Cyclin-dependent protein kinases (CDKs) are responsible for
controlling eukaryotic cell division cycle [30]. In complex cell
cycles, they also integrate extracellular and intracellular signals to
regulate cell cycle events in response to signals from the
environment or cellular damage and to control the transition to
subsequent phases of the cycle [30]. CDKs are small serine/
threonine protein kinases that require association with a cyclin
subunit for their activation [31]. CDKs are the catalytic subunits
of heterodimeric complexes that are activated or inactivated at
specific stages of the cell cycle triggering the next cell cycle events
[8]. Each catalytic CDK subunit can associate with different
cyclins, and this determines which one is phosphorylated by the
cyclin-CDK complex [32].
Roscovitine (Rosco) is a purine derivative that inhibits CDKs by
binding to the catalytic domain of the CDK molecule in the place
of ATP and blocks the transfer of a phosphate group to the
substrate [33]. As an inhibitor of CDK, Rosco is widely used as an
anti-cancer drug and is capable of inducing apoptosis in isolated B-
CLL cells by caspase activation and modulation of bcl-2 family
proteins [34].
In the current study the tick embryo cell line BME26 was
incubated for a period of between 24 and 48 h in medium
supplemented with roscovitine. The observed dose-dependent
decrease in cell viability was consistent with past findings with
rabbit retinal pigment epithelial cells [35], glioma cells [36],
polymorphonuclear cell [37] and tumor cell lines [38,39]. The
data obtained with different concentrations of roscovitine at and
incubation times, in MTT assay and visual counting, suggest that
Figure 8. MTT viability assay of BME26 cells. BME26 cells were
incubated with different concentrations of roscovitine (a CDK inhibitor)
or DMSO 0.1% (control) for 24 h (gray bar) and 48 h (grid bar) and then
cell viability was determined by the MTT assay. After incubation the
medium was removed and added MTT for 2 h. Reaction was read in
spectrophotometer at 570 nm. Graph represents three independent
experiments in triplicate. On all tested concentrations, with the
exception of roscovitine 75 mM for 24 h, values of roscovitine groups
were significantly different (One-way analysis of variance—ANOVA,
p,0.05) as compared to the control groups.
doi:10.1371/journal.pone.0076128.g008
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it induces cell death instead of reducing cellular metabolic activity
[40].
R. microplus CDKs may present suitable targets whose blockade
may interfere with the vital developmental processes of this tick,
such as egg production and embryogenesis. Ticks, like many other
hematophagous arthropods have high fecundity, and a female tick
may lay up to 2,500 eggs. The transcriptome analysis study
conducted in the present study showed that Rm-CDKs 1 and 10
are highly upregulated in the ovaries. It seems that the genes
coding for these proteins are highly expressed in the adult female
tick and that these motherly expressed genes could be crucial to
embryo development and consequently to the biological success of
this species reproduction. Consequently, cDNAs corresponding to
the ORFs of the two CKDs were cloned and the deduced protein
sequences utilized in silico structural analyses. BLAST searches and
Eukaryotic Linear Motif Resource simulation indicated the
presence of ATP-binding functional motifs and Caspase 3–7
recognition. This is supported by docking models that showed
roscovitine could inhibit both Rm-CDKs 1 and 10 by binding it to
the putative ATP-binding site. This interaction between roscov-
Figure 10. Identification of Rm-CDKs in BME26 cells. RT-PCR of BME26 cells showing the transcription of Rm-CDK1, 2, 5, 7, 8, 10, 11 and 14 in
BME26 cells. ELF1A was used as a positive control. WM – weight marker; ELF – constitutive gene (108 bp); 1 – CDK1 (148 bp); 10 – CDK10 (155 bp); 2 –
CDK2 (149 bp); 5 – CDK5 (151 bp); 7 – CDK7 (147 bp); 8 – CDK8 (152 bp); 9 – CDK9 (155 bp); 11 – CDK11 (150 bp); 14 – CDK14 (149 bp).
doi:10.1371/journal.pone.0076128.g010
Figure 9. Hematoxylin-eosin staining of the BME26 cell line upon exposure to roscovitine BME26 cells after 24 h of incubation with
different concentrations of roscovitine were stained with Hematoxylin and Eosin. A) Control with addition of 0.1% DMSO; B) rosco
150 mM; C) rosco 200 mM. The cells were observed under a light microscope. Magnification: 10X. The scale corresponds to 100 mm. Pictures are
representative of 3 independent experiments in triplicates. D) Graphic represents the number of cells in each treatment quantified by image J in three
different fields. On all tested concentrations, values of roscovitine groups were significantly different (One-way analysis of variance—ANOVA, p,0.05)
as compared to the control groups.
doi:10.1371/journal.pone.0076128.g009
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itine and CDKs 1 and 10 may extend to other R. microplus CDKs
owing to the largely conserved kinase active site but this is yet to be
evaluated.
Roscovitine can induce apoptosis by activating mitochondrial
caspase pathway or modulating the expression of the Bcl-2 family
member [41,42]. All R. microplus CDKs were obtained from
multiple tick tissues through RNA-sequencing. The analysis of
these protein sequences on the eukaryotic Linear Motif application
that predicts protein functional sites showed that Rm-CDK1 has 2
motifs for caspase 3–7 and Rm-CDK10 has one motif for caspase
3–7 and these motifs are located at different positions suggesting
functional non-redundancy. The presence of these motifs
reinforces the suggestion of a role for R. microplus CDKs in the
cell cycle similar to mammal CDKs, in which caspases 3 and 7
have a critical role in mediating the downstream mitochondrial
events of the intrinsic pathway in apoptosis [43–45]. CDKs are
important regulators of the cell cycle and are also known as cycle
checkpoint. During the process of maturation of the mammalian
oocyte, meiosis resumption occurs so the oocyte can mature and
be fertilized. This process is regulated by several proteins, among
them the CDKs. The regulation of CDK activity is directly related
to the process of maturation and the production of blastocysts [46–
48]. The addition of roscovitine, the CDK inhibitor, to the culture
medium delays the completion of meiotic maturation of the bovine
oocytes resulting in a higher blastocyst formation [12]. Farrell et
al. [49] demonstrated that the down-regulation of CDK1 activity
triggers the onset of late-replicating DNA and an increase in S-
phase length in Drosophila embryos. Extrapolating from this
observation, it is possible that R. microplus CDKs may participate
in egg development. The increased expression of the CDKs in the
ovaries from R. microplus suggests that, as in mammals, these
proteins could participate in egg development. The participation
of CDKs in the regulation of cell cycle and the formation of the
embryo has already been reported in other invertebrates such as C.
elegans [50] and Drosophila [51,52], and the parasite Leishmania
donovani [53].
This is the first report to demonstrate a cell cycle checkpoint
protein in arachnids and the reversal of its functions with an
inhibitor. Overall, these results suggest that CDKs are candidate
targets for blockade with roscovitine and related compounds,
which may present an alternative strategy for designing drugs
against R. microplus that target both oogenesis and embryogenesis
processes.
Supporting Information
Figure S1 FASTA-formatted file containing multiple sequences
of representative CDKs.
(FAS)
Figure S2 Phylogenetic analysis with representatives of the 20
types of CDK found in HomoloGene and ticks (R. microplus and I.
scapularis) CDKs constructed by the neighbor-joining method using
5.1 MEGA software. Bootstrap values of 500 simulations are
shown at the branches.
(PDF)
Figure S3 Ramachandran Plot of the comparative model of
Rm-CDK1 from R. microplus.
(TIF)
Figure S4 Ramachandran Plot of the comparative model of
Rm-CDK10 from R. microplus.
(TIF)
Figure S5 Structure of Rm-CDK1 from R. microplus obtained by
comparative modeling (A). The motifs for Caspase 3–7 SAKDA
and DKRGD identified in the Eukariotic Linear Motif Resource
are shown in the detail (B and C). SAKDA and DKRGD binding
surfaces along with the ATP binding pocket (D).
(TIF)
Figure S6 Structure of Rm-CDK10 from R. microplus obtained
by comparative modeling (A). The motif for Caspase 3–7 SLLDN
identified in the Eukariotic Linear Motif Resource is shown in the
detail (B). SLLDN binding surfaces along with ATP binding
pocket (C).
(TIF)
Figure S7 Crystal Structure of roscovitine Bound to Human
CDK2. Hydrogen atoms have been omitted for a better view.
Hydrogen bonds are depicted in blue dashed lines.
(TIF)
Figure S8 Superimposition of the top scored poses of roscovitine
(yellow carbon atoms) obtained by docking with Rm-CDK1 (A)
and Rm-CDK10 (B) models and roscovitine (magenta carbon
atoms) co-crystallized with human CDK2 (cyan). Hydrogen bonds
are depicted in blue dashed lines.
(TIF)
Figure S9 Representative substitutions of amino acid residues in
roscovitine binding site in Rm-CDK1 (A, deep blue) and Rm-
CDK10 (B, light gray) models compared to human CDK2 (cyan).
(TIF)
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42. Arısan ED, Coker A, Palavan-Ünsal N (2012) Polyamine depletion enhances the
roscovitine-induced apoptosis through the activation of mitochondria in
HCT116 colon carcinoma cells. Amino Acids 42(2–3): 655–65.
43. Shi Y (2004) Caspase activation, inhibition, and reactivation: a mechanistic view.
Protein Sci 13:1979–87.
44. Lakhani SA, Masud A, Kuida K, Porter GA Jr, Booth CJ, et al. (2006) Caspases
3 and 7: key mediators of mitochondrial events of apoptosis. Science 311:847–
51.
45. Fiandalo MV, Kyprianou N (2012) Caspase control: protagonists of cancer cell
apoptosis. Exp. Oncol 34:165–75.
46. Vigneron C, Nuttinck F, Perreau C, Reinaud P, Charpigny G, et al. (2003)
Effect of roscovitine, a cdk1 inhibitor, and of the presence of oocyte on bovine
cumulus cell expansion and cyclooxygenase-2 expression. Mol Reprod Dev
65:114–21.
47. Coy P, Romar R, Payton RR, McCann L, Saxton AM, et al. (2005)
Maintenance of meiotic arrest in bovine oocytes using the S-enantiomer of
roscovitine: effects on maturation, fertilization and subsequent embryo
development in vitro. Reprod 129: 19–26.
48. Barretto LS, Caiado Castro VS, Garcia JM, Mingoti GZ (2007) Role of
roscovitine and IBMX on kinetics of nuclear and cytoplasmic maturation of
bovine oocytes in vitro. Anim Reprod Sci 99(1–2): 202–7.
49. Farrell JA, Shermoen AW, Yuan K, O’Farrell PH (2012). Embryonic onset of
late replication requires Cdc25 down-regulation. Genes Dev 26: 714–725.
50. Ellefson ML, McNally FJ (2011) CDK-1 inhibits meiotic spindle shortening and
dynein-dependent spindle rotation in C. elegans. J Cell Biol 193: 1229–44.
51. Icreverzi A, de la Cruz AF, Van Voorhies WA, Edgar BA (2012) Drosophila
cyclin D/Cdk4 regulates mitochondrial biogenesis and aging and sensitizes
animals to hypoxic stress. Cell Cycle 11(3): 554–68.
52. Di Talia S, Wieschaus EF (2012) Short-term integration of Cdc25 dynamics
controls mitotic entry during Drosophila gastrulation. Dev Cell 22(4): 763–74.
53. Maity AK, Goswami A, Saha P (2011) Identification of substrates of an S-phase
cell cycle kinase from Leishmania donovani. FEBS Lett 2; 585(17): 2635–9.
Characterization of CDKs in Cattle Tick
PLOS ONE | www.plosone.org 12 October 2013 | Volume 8 | Issue 10 | e76128
